A

A Canadian Trademark Information

Biochemicals, namely, monoclonal antibodies and fragments thereof for research and development, for general manufacturing and for use in the manufacture of pharmaceuticals; cell lines for research and development, for general manufacturing and for use in the manufacture of pharmaceuticals; pharmaceuticals, namely, monoclonal antibodies and fragments thereof for clinical, diagnostic and therapeutic use as anti-infectives and anti-inflammatories and for the treatment of cancer and autoimmune diseases; cell lines for clinical, diagnostic and therapeutic use as anti-infectives and anti-inflammatories and for the treatment of cancer and autoimmune diseases; and animal embryos for laboratory use. Pharmaceutical and biological product development consultation; and pharmaceutical and biological product development for others.Biochemicals, namely, monoclonal antibodies and fragments thereof for research and development, for general manufacturing and for use in the manufacture of pharmaceuticals; cell lines for research and development, for general manufacturing and for use in the manufacture of pharmaceuticals; pharmaceuticals, namely, monoclonal antibodies and fragments thereof for cli...
Classification Information
Class Code: 001 - Chemical Products
Description: Chemicals and adhesives
Class Code: 031 - Natural Agricultural Products
Description: Agricultural, horticultural and forestry
Class Code: 042 - Computer & Software Services & Scientific Services
Description: Computer and scientific
Class Code: 005 - Pharmaceutical Products
Description: Pharmaceuticals and herbicides
Matter History Events
Status Date Record Status Description
2019-09-19 Registration cancelled - Expunged - Failure to Renew
2019-02-27 National prosecution history entry - Renewal Notice Sent
2018-07-10 National prosecution history entry - Nice Classification Courtesy Letter Sent
2004-02-05 Registration published - Registered
2003-12-19 National prosecution history entry - Allowed
2003-12-19 National prosecution history entry - Allowance Notice Sent
2003-10-01 Application published - Advertised
2003-08-25 Application accepted - Approved
2003-04-02 National prosecution history entry - Correspondence Created
2002-12-13 National prosecution history entry - Examiner's First Report
2002-12-12 National prosecution history entry - Search Recorded
2001-09-10 National prosecution history entry - Note to file
2001-07-27 Filing date accorded - Formalized
2001-07-09 National prosecution history entry - Created
2001-06-29 Application filed - Filed
Word Mark: A
Current Status:
Registration cancelled
DEAD Mark!
9/19/2019
Application Number: 1108172
Filing Date: Friday, June 29, 2001
Filing Place: Canada
Registration Date: Thursday, February 5, 2004
Registration Number: TMA601435
Register Type: Primary
Type Of Mark: Trademark
Mark Feature: Figurative
Use In Commerce: Yes
Publication Registration: Wednesday, October 1, 2003
Opposition: 10/1/2003 - 10/1/2003
Last Applicant/Owner: *********
**********
***** ****
Correspondent: Not provided
Logo Design Information
Design Feature:
(1) Circles or ellipses containing one or more letters
(2) Circles or ellipses with inscriptions projecting beyond the circumference
(3) Ellipses
(4) Circles or ellipses with dark surfaces or parts of surfaces
(5) One circle or ellipse
(6) Lines or bands forming an angle -- Note: Including chevrons and arrowheads formed by lines or bands.
(7) Circles or ellipses with one or more triangles and/or lines forming an angle
(8) Letters presenting a special form of writing
(9) One letter
(10) Letters linked to or containing a figurative element -- Note: Letters representing a human being or a part of the human body, an animal or a part of an animal's body, a plant, a heavenly body, a natural phenomenon or an object are classified in division 27.3.
Goods and Services Information
Description:
(1) - Biochemicals, namely, monoclonal antibodies and fragments thereof for research and development, for general manufacturing and for use in the manufacture of pharmaceuticals; cell lines for research and development, for general manufacturing and for use in the manufacture of pharmaceuticals; pharmaceuticals, namely, monoclonal antibodies and fragments thereof for clinical, diagnostic and therapeutic use as anti-infectives and anti-inflammatories and for the treatment of cancer and autoimmune diseases; cell lines for clinical, diagnostic and therapeutic use as anti-infectives and anti-inflammatories and for the treatment of cancer and autoimmune diseases; and animal embryos for laboratory use.
(2) - Pharmaceutical and biological product development consultation; and pharmaceutical and biological product development for others.
(3) - Biochemicals, namely, monoclonal antibodies and fragments thereof for research and development, for general manufacturing and for use in the manufacture of pharmaceuticals; cell lines for research and development, for general manufacturing and for use in the manufacture of pharmaceuticals; pharmaceuticals, namely, monoclonal antibodies and fragments thereof for clinical, diagnostic and therapeutic use as anti-infectives and anti-inflammatories and for the treatment of cancer and autoimmune diseases; cell lines for clinical, diagnostic and therapeutic use as anti-infectives and anti-inflammatories and for the treatment of cancer and autoimmune diseases; and animal embryos for laboratory use.
(4) - Pharmaceutical and biological product development consultation; and pharmaceutical and biological product development for others.
(5) - Biochemicals, namely, monoclonal antibodies and fragments thereof for research and development, for general manufacturing and for use in the manufacture of pharmaceuticals; cell lines for research and development, for general manufacturing and for use in the manufacture of pharmaceuticals; pharmaceuticals, namely, monoclonal antibodies and fragments thereof for clinical, diagnostic and therapeutic use as anti-infectives and anti-inflammatories and for the treatment of cancer and autoimmune diseases; cell lines for clinical, diagnostic and therapeutic use as anti-infectives and anti-inflammatories and for the treatment of cancer and autoimmune diseases; and animal embryos for laboratory use.
(6) - Pharmaceutical and biological product development consultation; and pharmaceutical and biological product development for others.
Trademarkia is the largest search engine for U.S., China, European Union, Canada, and Australia Trademarks. Each month hundreds of trademarks around the world are filed by licensed attorneys in the Trademarkia network law firms! You can register your trademark in 180+ countries in the world through Trademarkia Network. Trademarkia.com is a free search engine of publicly available government records. Trademarkia.com is not a law firm and does not represent owners & correspondents listed on this page.
What You Can Do:

This mark may be available for re-registration. You can apply for it through Trademarkia at a low cost of $449!

Trademarkia.com will perform a final search in order to verify that this mark is available for Canada Trademark re-registration. All Trademarkia services are backed by a 100% satisfaction guarantee.

Trademarkia lets you see how your personal name, product name, trademark name or username is being used on any of 530+ new and popular social networks. Be the first to reserve your name and get help stopping others from using it - all in one place!
As seen on